Some countries, like Britain, Finland and the Netherlands, almost always vote in favor of approving newGMOs.
2
Biotech companies also are concerned that consumer sentiment is causing regulators to slow down approvals of newGMOs, said Dow AgroSciences Brad Shurdut.